LDL-cholesterol / ApoB ratio
Heart healthAlso known as: LDL-C to ApoB ratio, LDL particle ratio
This ratio compares LDL cholesterol to apolipoprotein B (ApoB), a protein present on atherogenic lipoproteins.
It helps distinguish how cholesterol is distributed among particles. A lower ratio suggests many small, dense LDL particles, which are more prone to penetrate artery walls and drive plaque formation.
Reference range
Source: Ahead Health benchmark
Reference ranges may vary between labs and assays. Always interpret results with your healthcare provider.
Why this matters
This ratio identifies cardiovascular risk beyond what LDL cholesterol alone shows by revealing dangerous particle characteristics. A low ratio indicates small, dense LDL particles that are more atherogenic - they penetrate arterial walls easier, oxidize faster, and cause more inflammation. These smaller particles are strongly linked to heart disease, even when total LDL cholesterol appears normal. Conversely, a higher ratio suggests larger, less dangerous particles.
The ratio helps identify patients with "hidden" cardiovascular risk who have normal LDL cholesterol but abnormal particle patterns, common in metabolic syndrome, diabetes, and insulin resistance.
How this connects to other biomarkers
- Low ratio identifies small dense LDL pattern requiring lifestyle changes targeting insulin resistance, not just LDL reduction.
- The ratio improving with omega-3s or exercise confirms treatment is successfully modifying particle quality, not just quantity.
How often should I test LDL-cholesterol / ApoB ratio?
Most adults benefit from checking the LDL to ApoB ratio yearly as part of a lipid panel.
At baseline / for screening: Once every 12 months from age 30, alongside the rest of your lipid panel. Earlier and more frequent if you have a family history of early cardiovascular disease, elevated Lp(a), or known cardiovascular risk factors.
When monitoring an intervention or change: Retest 6 to 12 weeks after a sustained lifestyle change, such as reducing saturated fat, adding soluble fibre, meaningful weight loss, or a new aerobic routine. The same window applies after starting or adjusting cholesterol-lowering medication (statin, ezetimibe, bempedoic acid, PCSK9 inhibitor).
Included in
Ready to check your health?
Get a comprehensive view of your biomarkers with our advanced check-up packages.